Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation
EARLY_PHASE1
To evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, a...
Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers
PHASE2
The primary objective is to compare the anti-tetanus neutralizing antibody ...
Status
Completed
Location
The First Affiliated Hospital of Shantou University Medical College
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
PHASE1
A Randomized, Double-blind, Controlled, Dose-escalation Phase I Clinical Tr...
Status
Enrolling By Invitation
Location
Lanzhou Institute of Biological Products Co., Ltd.